Physicians show continued adoption of mobile and social media for professional purposes, as well as increasing dependency on digital resources at the point of care, according to pharmaceutical and healthcare market research company Manhattan Research's latest Taking the Pulse® study of over 2,000 U.S. physicians. The tenth version of this landmark research and strategic advisory service is focused on which technologies physicians have adopted, how they are currently using them, and how they plan to use them in the future. Taking the Pulse® v10.0 provides a rich data set with topical insights for pharma marketers, agencies, physician content and technology providers, and other parties interested in connecting with physicians.

"In 2010, the conversation has shifted away from whether physicians are online to understanding the degree to which digital content is changing the way physicians practice medicine," said Meredith Ressi, VP of research at Manhattan Research. "Professional use of smartphones and online user-generated content are no longer early adopter activities of a tech-savvy few -- these types of activities are the norm for the majority of physicians today."

  Key topics covered in the research include:    --  Online and Offline Professional Information Sources: Online and       offline information sources used, including textbooks, journals,       conferences, CME, reps, search engines, sites visited   --  Mobile Technology Adoption: Device adoption by platform (iPhone,       BlackBerry, Palm, Android); professional activities conducted on the       smartphone; top mobile apps and websites used   --  Online User-Generated Content: Use of physician-only communities,       messageboards and blogs   --  General Access and Technology Profile: Practice technology profile;       frequency of Internet use; frequency of professional activities online       and offline   --  Patient Interaction and Education: Patients bringing information into       office; sites recommended to patients; types of patient education       sources of interest   --  Digital Health Infrastructure: Adoption of electronic medical records       (EMR); electronic prescribing; impact of ARRA on decision to implement       EMR system    Webinar April 29 - Register Today!  

Mrs. Ressi will host a complimentary webinar previewing the research topics covered in the Taking the Pulse® v10.0 study on Thursday, April 29 at 11am EDT.

Register here:

For assistance in signing up, please email your time preference to or call 212-255-7799.

About Taking the Pulse®

Taking the Pulse® v10.0 is a market research and strategic advisory service focused on which technologies physicians have adopted, how they are currently using them, and how they plan to use them in the future. The study was conducted in Q1 2010 via online and offline survey methodology among a nationally representative sample of 2,033 U.S. practicing physicians. Broad physician market research can be segmented to provide insights for over twenty specialist groups. For additional product and subscription information, please email, call 1.888.680.0800, ext. 2, or visit

About Manhattan Research

Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm and conducts annual research studies covering eHealth trends among physicians and consumers, including Taking the Pulse®, Taking the Pulse® Nurses, Taking the Pulse® Europe, Taking the Pulse® Asia, Cybercitizen Health®, Cybercitizen Health® Europe, ePharma Consumer®, and ePharma Physician®. Broad consumer and physician research is complemented by targeted analysis for over 100 consumer therapeutic segments and physician specialist segments. For more information, please contact or visit

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Manhattan Research   Maureen Malloy   212-255-7799 

First Call Analyst:
FCMN Contact:

SOURCE: Manhattan Research

CONTACT: Maureen Malloy of Manhattan Research, +1-212-255-7799,

AstraZeneca/Targacept's TC-5214 Will Become Decision Resources' Proprietary Clinical Gold Standard In 2013 Through 2018 For Treatment Resistant Depression

View Now